Start page Newsroom All news Newsroom type All Releases Articles year All years 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 NEJM Evidence publishes results from Phase I/IIa CYPIDES trial with ODM-208 12/27/2023 Press release Mathias Herrlin: The Phase1 trainee programme offered the opportunity to work on a larger scale and receive support in overcoming challenges 12/22/2023 We are Orion New treatments for cancer – Three breakthroughs that will make cancer treatment more effective in the future 12/19/2023 Science and Partnering 87 000 Orion Corporation A shares converted into B shares 12/4/2023 Stock exchange release Sharing of information helps in the development of new medicines – This is how data protection is ensured for clinical study participants 12/1/2023 Sustainability Through an apprenticeship, Christina Holappa qualified as a laboratory technician in record time 11/22/2023 We are Orion Phase 3 Clinical Trials with ODM-208 (MK-5684) posted to ClinicalTrials.gov database 11/21/2023 Press release Orion Animal Health receives FDA approval for Bonqat® (pregabalin oral solution) 11/20/2023 Press release Why don’t people take their prescribed medicines as directed? 11/17/2023 Your Health Orion Corporation: Managers’ transactions – Mikael Silvennoinen 11/16/2023 Managers transactions Orion Corporation: Managers’ transactions – Agendum Oy 11/16/2023 Managers transactions Orion Research Foundation grants EUR 1,112,000 for research in 2024 11/15/2023 Press release Having seizures is often only one part of epilepsy 11/14/2023 Your Health An assistant is a magician working in the background, whose expertise benefits the entire organisation 11/9/2023 We are Orion Pharmaceutical research ecosystem project aims to accelerate drug development and deliver substantial savings 10/30/2023 Science and Partnering Orion Group Interim Report January–September 2023 10/26/2023 Stock exchange release Working to ensure pharmaceutical and patient safety 10/25/2023 We are Orion Orion studies drug interactions very closely – to ensure safe medication 10/18/2023 Sustainability
